Abstract
The rational design of artificial carriers for anchoring multiple copies of B and/or T cell epitopes, built-in vaccine adjuvants and "promiscuous" T cell epitopes for the construction of conjugates as antigenic substrates or potent immunogens has been the stimulus of intensive efforts nowadays. The unambiguous composition, the reliability and the versatility of the production of reconstituted antigens or immunogens has found a great number of biochemical applications in developing immunoassays of high sensitivity, specificity and reproducibility and in generating site-specific antibodies for usage as human vaccine candidates. In this review are summarized different types of artificial carriers currently used as dendrimers bearing branching segments, multimeric core matrices and templates with built-in folding devices. Emphasis is given to the construction and application of a helicoid-type Sequential Oligopeptide Carrier (SOCn) developed in our laboratory. The beneficial structural elements of SOCn induce a favorable arrangement of the conjugated peptides, which also retain their initial "active" conformation, so that potent antigens and immunogens are generated.
Keywords: Dendrimers, multimeric core matrices, templates with built-in folding devices, Sequential Oligopeptide Carriers, artificial conjugates, immunoassays, site specific antibodies
Current Topics in Medicinal Chemistry
Title: Artificial Carriers: A Strategy for Constructing Antigenic/Immunogenic Conjugates
Volume: 6 Issue: 16
Author(s): Maria Sakarellos-Daitsiotis, Dimitrios Krikorian, Eugenia Panou-Pomonis and Constantinos Sakarellos
Affiliation:
Keywords: Dendrimers, multimeric core matrices, templates with built-in folding devices, Sequential Oligopeptide Carriers, artificial conjugates, immunoassays, site specific antibodies
Abstract: The rational design of artificial carriers for anchoring multiple copies of B and/or T cell epitopes, built-in vaccine adjuvants and "promiscuous" T cell epitopes for the construction of conjugates as antigenic substrates or potent immunogens has been the stimulus of intensive efforts nowadays. The unambiguous composition, the reliability and the versatility of the production of reconstituted antigens or immunogens has found a great number of biochemical applications in developing immunoassays of high sensitivity, specificity and reproducibility and in generating site-specific antibodies for usage as human vaccine candidates. In this review are summarized different types of artificial carriers currently used as dendrimers bearing branching segments, multimeric core matrices and templates with built-in folding devices. Emphasis is given to the construction and application of a helicoid-type Sequential Oligopeptide Carrier (SOCn) developed in our laboratory. The beneficial structural elements of SOCn induce a favorable arrangement of the conjugated peptides, which also retain their initial "active" conformation, so that potent antigens and immunogens are generated.
Export Options
About this article
Cite this article as:
Sakarellos-Daitsiotis Maria, Krikorian Dimitrios, Panou-Pomonis Eugenia and Sakarellos Constantinos, Artificial Carriers: A Strategy for Constructing Antigenic/Immunogenic Conjugates, Current Topics in Medicinal Chemistry 2006; 6 (16) . https://dx.doi.org/10.2174/156802606778194190
DOI https://dx.doi.org/10.2174/156802606778194190 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances and Challenges in the Synthesis of Highly Oxidised Natural Phenols with Antiviral, Antioxidant and Cytotoxic Activities
Current Medicinal Chemistry Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry Anticancer Activity of Ferrocenylthiosemicarbazones
Anti-Cancer Agents in Medicinal Chemistry Interactions of Polyphenols with Plasma Proteins: Insights from Analytical Techniques
Current Drug Metabolism In Vitro Anticancer Evaluation of Some Synthesized 2H-Quinolinone and Halogenated 2H-Quinolinone Derivatives as Therapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry The Impact of Combinatorial Methodologies on Medicinal Chemistry
Current Topics in Medicinal Chemistry Electronic Noses in Medical Diagnostics
Current Medicinal Chemistry Phenolic Imidazole Derivatives with Dual Antioxidant/Antifungal Activity: Synthesis and Structure-Activity Relationship
Medicinal Chemistry Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance
Current Topics in Medicinal Chemistry New Heterocyclic Compounds: Synthesis, Antioxidant Activity and Computational Insights of Nano-Antioxidant as Ascorbate Peroxidase Inhibitor by Various Cyclodextrins as Drug Delivery Systems
Current Drug Delivery Synthesis of 1,2,4-triazole Derivatives: Binding Properties on Endothelin Receptors
Medicinal Chemistry Synthesis and Anti-Oxidant Evaluation of Some Novel Sulfa Drugs
Letters in Drug Design & Discovery Advances of Infrared Spectroscopic Imaging and Mapping Technologies of Plant Material
Current Bioactive Compounds Emerging Vascular Risk Factors in Women: Any Differences from Men?
Current Medicinal Chemistry Effect of Surfactant Chain Length on Emulsification Dynamics of Self Emulsifying Formulation of Poorly Soluble Drug
Current Drug Delivery Insights into Oxidative Stress: The Isoprostanes
Current Medicinal Chemistry 4-Oxa-1-azabicyclo[3.2.0]heptan-7-one Derivatives as Anti-Tumor Agents
Current Medicinal Chemistry - Anti-Cancer Agents Antibacterial Activity of Polyphenols
Current Pharmaceutical Biotechnology Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design γ-AApeptides as a New Strategy for Therapeutic Development
Current Medicinal Chemistry